XOMA Royalty Down Nearly 11%, on Pace for Largest Percent Decrease Since January 2023 -- Data Talk

Dow JonesOct 30 23:18

H.C. Wainwright Maintains XOMA Corp(XOMA.US) With Buy Rating, Maintains Target Price $117

Futu NewsOct 22 23:32 · Ratings

XOMA Royalty Significantly Expands Its Royalty and Milestone Portfolio With the Addition of Over 60 Early-Stage Programs From Twist Bioscience

Globe NewswireOct 22 20:00

While Shareholders of XOMA Royalty (NASDAQ:XOMA) Are in the Black Over 1 Year, Those Who Bought a Week Ago Aren't so Fortunate

Simply Wall StSep 27 18:01

XOMA Corp - 8.375% DP PFD B Declares $0.5234 Dividend

Seeking AlphaSep 23 20:49

XOMA Royalty Says Zevra Therapeutics Received FDA Approval For MIPLYFFA; Says It Is Entitled To Receive Mid-single Digit Royalty On MIPLYFFA Sales And Up To $52.6M In Milestones

BenzingaSep 23 18:34